Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review

A Tufan, H LACHMANN - Turkish Journal of Medical …, 2020 - journals.tubitak.gov.tr
Abstract Familial Mediterranean fever (FMF)(OMIM# 249100) is the most common hereditary
autoinflammatory disease in the world. FMF is caused by gain of function mutations of MEFV …

Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management

S Özen, ED Batu, S Demir - Frontiers in immunology, 2017 - frontiersin.org
Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory
disease (AID) affecting mainly the ethnic groups originating from Mediterranean basin. The …

[HTML][HTML] EULAR recommendations for the management of familial Mediterranean fever

S Ozen, E Demirkaya, B Erer, A Livneh… - Annals of the …, 2016 - ard.bmj.com
Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory
disease, but many rheumatologists are not well acquainted with its management. The …

Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature

JCH van der Hilst, M Moutschen… - … : Targets and Therapy, 2016 - Taylor & Francis
Introduction In 5%–10% of patients with familial Mediterranean fever (FMF), colchicine is not
effective in preventing inflammatory attacks. Another 5%–10% of patients are intolerant to …

The use of interleukine-1 inhibitors in familial Mediterranean fever patients: a narrative review

V Hentgen, C Vinit, A Fayand… - Frontiers in …, 2020 - frontiersin.org
Purpose: Familial Mediterranean fever (FMF) is the most common monogenic auto-
inflammatory disease characterized by recurrent attacks of fever and serositis. It is …

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)

G El Hasbani, A Jawad, I Uthman - Orphanet journal of rare diseases, 2019 - Springer
Abstract Background Familial Mediterranean Fever (FMF), an autoinflammatory disease, is
characterized by self-limited inflammatory attacks of fever and polyserositis along with high …

The clinical role of anakinra in the armamentarium against familial Mediterranean fever

K Parlar, MB Ates, BH Egeli… - Expert Review of Clinical …, 2024 - Taylor & Francis
ABSTRACT Introduction Familial Mediterranean Fever (FMF) is the most common
autoinflammatory disease that has mainly been treated with colchicine since 1972. A …

Familial mediterranean fever

S Padeh, Y Bilginer, S Ozen - Textbook of Autoinflammation, 2019 - Springer
Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease characterized
by recurrent, sporadic, self-limited episodes of fever accompanied by peritonitis, pleuritis …

The efficacy of a single-dose anakinra injection during disease attack in pediatric familial Mediterranean fever

SO Cebeci, M Yildiz, A Gunalp, MN Cebi… - Rheumatology …, 2024 - Springer
The aim of this retrospective study is to evaluate the efficacy of a single-dose anakinra
during familial Mediterranean fever (FMF) attacks and its effect on the duration, severity, and …

Effectiveness of canakinumab in colchicine-and anakinra-resistant or-intolerant adult familial Mediterranean fever patients: a single-center real-life study

H Babaoglu, O Varan, H Kucuk, N Atas… - JCR: Journal of …, 2020 - journals.lww.com
Objective We aimed to present our single-center real-life experience of canakinumab use in
adult patients with familial Mediterranean fever (FMF). Methods Data were derived from the …